FDA Grants 510(k) Clearance to AI-Powered Bone Health Technologies for Orthopedic Care
核心洞察
Naitive Technologies (搜索) received FDA 510(k) clearance for OsteoSight (搜索), an AI-driven software that assesses bone mineral density (搜索) using standard X-rays to identify undiagnosed osteoporosis (搜索) patients.
The technology addresses a critical healthcare gap where 70% of patients with low bone mineral density (搜索) remain undiagnosed until fractures occur, potentially enabling earlier intervention and improved outcomes.
Orthopedic Driven Imaging (搜索) also secured FDA clearance for its S-ODI See-arm (搜索) surgical c-arm system, designed to enhance surgical procedures through advanced imaging hardware and AI-powered software integration.
Two medical technology companies have secured FDA 510(k) clearances for innovative orthopedic imaging solutions that leverage artificial intelligence to improve bone health assessment and surgical outcomes.
AI-Powered Osteoporosis Detection Breakthrough
Naitive Technologies (搜索) announced FDA clearance for OsteoSight (搜索), an AI-driven software platform that enables opportunistic assessment of bone mineral density (搜索) (BMD) using standard X-rays acquired for other clinical concerns, such as pain associated with arthritis (搜索) or falls. The technology addresses a significant healthcare challenge, as osteoporosis (搜索) impacts millions of Americans and costs healthcare systems billions annually, yet 70% of patients with low BMD remain undiagnosed until a fracture occurs.
OsteoSight (搜索) analyzes routine X-rays of the hip or pelvis in patients 50 years and older, opportunistically identifying cases at risk for low BMD and providing notification reports to aid interpreting physicians in prompting clinical assessment of bone health. The device earned FDA Breakthrough Device designation in 2023 and has been validated in peer-reviewed research.
"The FDA's clearance of OsteoSight (搜索) technology represents a critical step forward in orthopedics," said Dr. Javad Parvizi, former President of the American Association of Hip and Knee Surgeons (AAHKS). "By utilizing X-rays that are already part of routine practice, this technology enables the orthopedic community to identify patients with poor bone health, who otherwise go unnoticed. Having this insight at the point of care can help surgeons and practices intervene earlier, improve surgical planning, and ultimately enhance patient outcomes."
Advanced Surgical Imaging Platform
Orthopedic Driven Imaging (搜索) (ODI) received FDA 510(k) clearance for its S-ODI See-arm (搜索) surgical c-arm system, developed in partnership with Imaging Engineering (搜索). The approval initiates ODI's strategy to streamline surgical procedures and enhance clinical outcomes through an integrated ecosystem comprising advanced imaging hardware and AI-powered software for individualized and adaptable surgical planning and execution.
The company's innovations build on decades of scientific research, including dynamic kinematic analysis pioneered by Scott Banks, PhD, co-founder of ODI and Knee Society member. "With ODI, we are re-engineering advanced imaging and analysis, giving surgeons practical tools they can use with their patients across the entire continuum of care," said Dr. Banks.
Clinical Impact and Commercial Advancement
ODI's platform aims to close the information loop for surgeons by providing quantitative, real-time, dynamic 3D insights before, during, and after orthopedic procedures. Meanwhile, Naitive is advancing commercial partnerships to bring OsteoSight (搜索) into orthopedic practices across the United States as the foundation for a comprehensive bone health platform designed to expand proactive care and create new growth opportunities for providers.
"We are proud that OsteoSight (搜索) has received FDA 510(k) clearance," said Dr. Will Briggs, CEO of Naitive. "It reflects the dedication of our team and validates the urgency of the problem we are solving. Millions of patients live with undetected osteoporosis (搜索), and orthopedic practices are uniquely positioned to change that."